Regulatory

RAPS launches 2014 global regulatory survey.
News
|

RAPS launches 2014 global regulatory survey

Survey asks regulatory pros about their jobs, backgrounds, and compensation. Results will be available in June.
E-BOOK SPECIAL REPORT
42 Best Package Designs: 2014 edition
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!
Dr. Michael Drues, Vascular Sciences
Column/Opinion
|

Printing medical devices at home is just the beginning: Part II

Is it time for a new business model for medical devices? And where does packaging fit into advanced 3D printing technology?
This is a purchased photo of a drug strip made by Ranbaxy and used solely for illustrative purposes.
News
|

FDA prohibits Ranbaxy's Toansa, India facility from producing and distributing drugs for the U.S. market

The facility is now subject to certain terms of a consent decree of permanent injunction entered against Ranbaxy in Jan. 2012.
Regulatory issues represented the primary challenge for combination product makers, closely followed by processing and manufacturing, and then fill/finish and packaging. These details provide keen insight into manufacturer needs, particularly for consultants and suppliers involved in these topical areas.
News
|

Regulatory burdens weigh on combination product manufacturers

Regulatory matters, processing and manufacturing, as well as fill/finish and packaging rank as the most challenging areas for makers of combination products.
Senator Charles Schumer calls for safer packaging for children’s medicine bottles in effort to help prevent emergency room visits.
News
|

Could 'flow restrictors' help reduce medication overdoses?

Senator Charles Schumer calls for safer packaging for children’s medicine bottles in effort to help prevent emergency room visits.
Gail E. Radcliffe, Ph.D., is President of Radcliffe Consulting, Inc.
Column/Opinion
|

Regulatory issues factor heavily into the IVD market

In this question-and-answer dialogue, Gail Radcliffe of Radcliffe Consulting discusses in vitro diagnostics, focusing on regulatory and labeling issues.
Shown in this photo is a fake Lamisil three-pack.
Column/Opinion
|

Counterfeit med market grows worldwide

DQSA to help address global counterfeit drug market, recently estimated at more than $430 billion annually by the WHO.
Eric F. Greenberg is a Contributing Editor and Legal & Regulatory columnist for Healthcare Packaging.
Column/Opinion
|

How do you like your FDA?

Would lower government burdens on industry provide sufficient protection for the public?
Dirk Rodgers
Column/Opinion
|

A perspective on DQSA, preemption, and pedigree

Now that DQSA is law, any previous investments to meet California pedigree law can be repurposed to meet the new federal law.
Author Katherine Eban’s (shown here) book “Dangerous Doses,” exposed the dark side of America’s pharmaceutical trade. Here, the investigative journalist looked at the epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans.
Column/Opinion
|

Your Top 10 Healthcare Packaging stories from 2013

Serialization stories dominated the list among Healthcare Packaging online readers, but the top-read story of the year revealed some dirty deeds.

Pages

Subscribe to Regulatory

 

Newsletters
Don’t miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST

New Issue Alert

Packaging World Magazine

eClip

Breaking packaging news

Packaging Insights

Pertinent packaging issues

PACKAGE DESIGN/
DEVELOPMENT

Greener Package

Sustainable packaging

Shelf Impact

Package design strategies

Each newsletter ranges in frequency from once per month to a few times per month at most.